Personalized Tissue Microablation System with AI, IoT, and Blockchain Integration
Legal Citation
Summary of the Inventive Concept
A novel system and method for tissue microablation that combines fractional treatment patterns with AI-powered optimization, IoT-enabled real-time feedback, and blockchain-based secure storage and sharing of personalized treatment protocols.
Background and Problem Solved
The original patent described a system and methods for laser microablation, providing selection and control of treatment 'spots' and resulting macro-spots and microchannels created in human tissue. However, this technology had limitations in terms of personalized treatment and real-time feedback. The new inventive concept addresses these limitations by integrating AI, IoT, and blockchain technologies to create a more powerful and personalized system.
Detailed Description of the Inventive Concept
The new system consists of a laser unit, a scanning device, and an AI-powered controller that optimizes treatment protocols based on individual skin characteristics and real-time feedback from IoT-enabled sensors. The system utilizes blockchain technology for secure storage and sharing of personalized treatment protocols, generated using a combination of AI-driven analysis and expert input. The system also includes a real-time monitoring module that uses laser Doppler vibrometry and machine learning algorithms to provide real-time feedback to the treatment protocol. Additionally, the system enables the creation of customizable, 3D-printed tissue models for testing and optimizing microablation treatment protocols.
Novelty and Inventive Step
The new claims introduce the innovative combination of AI, IoT, and blockchain technologies with fractional treatment patterns, which provides a synergistic effect in terms of personalized treatment, real-time feedback, and secure data management. This integration is not obvious from the original patent and provides a significant improvement over the prior art.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations could also include the integration of other technologies, such as robotics or augmented reality, to further enhance the system's capabilities.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the medical aesthetics and dermatology markets, where personalized and effective treatment solutions are in high demand. The system's ability to provide real-time feedback and secure data management also makes it attractive for use in clinical trials and research settings.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for tissue treatment, specifically laser microablation systems with a focus on dermatological and tissue modification procedures. Requires expertise in laser physics, medical device engineering, and minimally invasive treatment protocols
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device specialist with advanced degrees in bioengineering, experience in laser treatment technologies, understanding of tissue interaction with energy-based devices, and familiarity with computational optimization techniques
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies into existing microablation systems represents a predictable extension of known medical device innovation strategies. The fundamental microablation technique from the source patent provides a clear technical foundation for introducing advanced computational and monitoring technologies. The proposed variations represent standard technological convergence approaches commonly employed in medical device optimization and personalization.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,810 |
|---|---|
| Title | System and methods of tissue microablation using fractional treatment patterns |
| Assignee(s) | LUMENIS BE LTD. |